IKARIAN CAPITAL, LLC Revance Therapeutics, Inc. Transaction History

IKARIAN CAPITAL, LLC portfolio value:

$2.7M
portfolio value

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 100K shares 2.7M $27 100K